|
" New Anticancer Drugs "
edited by Stephen K. Carter, Yoshia Sakurai.
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
736759
|
| Doc. No
|
:
|
b556624
|
| Main Entry
|
:
|
edited by Stephen K. Carter, Yoshia Sakurai.
|
| Title & Author
|
:
|
New Anticancer Drugs\ edited by Stephen K. Carter, Yoshia Sakurai.
|
| Publication Statement
|
:
|
Berlin, Heidelberg: Springer Berlin Heidelberg, 1980
|
| Series Statement
|
:
|
Recent Results in Cancer Research, Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, 70.
|
| ISBN
|
:
|
3642813925
|
|
|
:
|
: 3642813941
|
|
|
:
|
: 9783642813924
|
|
|
:
|
: 9783642813948
|
| Contents
|
:
|
Of U.S.-Japan Joint Meeting on Phase I and II Clinical Trials --;The New NCI Screen and Its Implications for Clinical Evaluation --;The National Cancer Institute's Natural Products Antineoplastic Development Program --;Methodology of Phase I Study in Japan --;Methodology of Phase II Clinical Trial in Cancer --;Phase II Study of Antineoplastic Agents in Japan --;Clinical Strategy for Evaluation of Anthracycline Analogues --;Preliminary Clinical Study of Aclacinomycin A --;Preclinical and Clinical Studies on Chlorozotocin, a New Nitrosourea with Decreased Bone Marrow Toxicity --;Continuation of Phase II Study of 1-(4-Amino-2-Methylpyrimidine-5-yl)-Methyl-3-(2-Chloroethyl)-3-Nitrosourea Hydrochloride (ACNU) --;Review of Experimental Studies on Nitrosourea Derivates in Japan --;The Clinical Evaluation of Analogues, IV. Nitrosoureas --;Review of a New Antimetabolic Agent, 1-Hexylcarbamoyl-5-Fluorouracil (HCFU) --;Review of a New Antimetabolic Agent, 1,1-Bis(Tetrahydro-2-Furanyl)-5-Fluoro-2,4-Pyrimidinedione (FD-1) --;Effect and Mode of Action of N4-Behenoyl-?-D-Arabinofuranosylcytosine --;Strategy for Evaluation of a New Antitumor Agent in the Treatment of Breast Cancer --;Current Status of Breast Cancer Chemotherapy in Japan --;Present Status of Lung Cancer Chemotherapy in Japan --;Clinical Strategies in the Chemotherapy of Gastrointestinal Cancer --;Clinical Evaluation Strategy in Specific Disease Types --;Clinical Study of Gastrointestinal Cancer Chemotherapy in One Institute of Japan --;A Review of Therapeutic Strategies for Phase I-II Trials in Genitourinary Cancer --;Recent Results of Using a Sequential Combination of Bleomycin and Mitomycin C in the Treatment of Metastatic Cervical Cancer --;Pharmacologic and Clinical Studies of N4-Behenoyl-1-Beta-D-Arabinofuranosylcytosine.
|
| Subject
|
:
|
Medicine.
|
| Subject
|
:
|
Oncology.
|
| Subject
|
:
|
Toxicology.
|
| Added Entry
|
:
|
Stephen K Carter
|
|
|
:
|
Yoshia Sakurai
|
| |